Cercetătorii de la UC Berkeley au găsit un potențial nou tratament pentru obezitate și diabet. Diferența față de Ozempic, Wegovy, Mounjaro

GLP-1 medications have transformed metabolic disorder treatments but come with side effects. A new compound, TOFA, shows promise in enhancing energy expenditure without significant muscle loss. Research indicates TOFA may work synergistically with GLP-1 drugs, improving metabolic health in mice. However, its effects on humans remain untested.